213 related articles for article (PubMed ID: 34858328)
1. GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome.
Dahlgren J; Albertsson-Wikland K
Front Endocrinol (Lausanne); 2021; 12():737893. PubMed ID: 34858328
[TBL] [Abstract][Full Text] [Related]
2. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
Binder G; Baur F; Schweizer R; Ranke MB
J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
[TBL] [Abstract][Full Text] [Related]
3. IGF-I generation test in prepubertal children with Noonan syndrome due to mutations in the PTPN11 gene.
Bertelloni S; Baroncelli GI; Dati E; Ghione S; Baldinotti F; Toschi B; Simi P
Hormones (Athens); 2013; 12(1):86-92. PubMed ID: 23624134
[TBL] [Abstract][Full Text] [Related]
4. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
[TBL] [Abstract][Full Text] [Related]
5. Defective growth hormone (GH) secretion and short-term treatment in Noonan syndrome.
Soliman AT; Rajab A; el Zalabany M; alSalmi I; Fattah MA
Indian J Pediatr; 1998; 65(5):741-9. PubMed ID: 10773931
[TBL] [Abstract][Full Text] [Related]
6. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
[TBL] [Abstract][Full Text] [Related]
7. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
Binder G; Neuer K; Ranke MB; Wittekindt NE
J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF) levels in short, GH treated children: a distinct pattern of VEGF-C in Noonan syndrome.
Fuchs S; Gat-Yablonski G; Shtaif B; Lazar L; Phillip M; Lebenthal Y
J Endocrinol Invest; 2015 Apr; 38(4):399-406. PubMed ID: 25344824
[TBL] [Abstract][Full Text] [Related]
9. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
Romano AA; Dana K; Bakker B; Davis DA; Hunold JJ; Jacobs J; Lippe B
J Clin Endocrinol Metab; 2009 Jul; 94(7):2338-44. PubMed ID: 19401366
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment.
Noordam C; van der Burgt I; Sweep CG; Delemarre-van de Waal HA; Sengers RC; Otten BJ
Clin Endocrinol (Oxf); 2001 Jan; 54(1):53-9. PubMed ID: 11167926
[TBL] [Abstract][Full Text] [Related]
11. Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.
Zavras N; Meazza C; Pilotta A; Gertosio C; Pagani S; Tinelli C; Bozzola M
Ital J Pediatr; 2015 Oct; 41():71. PubMed ID: 26444854
[TBL] [Abstract][Full Text] [Related]
12. Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet® IOS and Answer Program.
Backeljauw P; Blair JC; Ferran JM; Kelepouris N; Miller BS; Pietropoli A; Polak M; Sävendahl L; Verlinde F; Rohrer TR
J Clin Endocrinol Metab; 2023 Sep; 108(10):2653-2665. PubMed ID: 36947589
[TBL] [Abstract][Full Text] [Related]
13. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
14. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
[TBL] [Abstract][Full Text] [Related]
15. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
16. The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.
Braz AF; Costalonga EF; Montenegro LR; Trarbach EB; Antonini SR; Malaquias AC; Ramos ES; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E671-7. PubMed ID: 22278433
[TBL] [Abstract][Full Text] [Related]
17. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
18. Growth and Adult Height in Girls With Turner Syndrome Following IGF-1 Titrated Growth Hormone Treatment.
Cleemann Wang A; Hagen CP; Nedaeifard L; Juul A; Jensen RB
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32421787
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
[TBL] [Abstract][Full Text] [Related]
20. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
de Waal WJ; Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL
Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
